Yamashita, H., Kitayama, J., Kanno, N., Yatomi, Y., & Nagawa, H. (2006). Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BioMed Central.
Čikaški stil citiranjaYamashita, Hiroharu, Joji Kitayama, Nobuko Kanno, Yutaka Yatomi, i Hirokazu Nagawa. Hyperfibrinogenemia Is Associated With Lymphatic As Well As Hematogenous Metastasis and Worse Clinical Outcome in T2 Gastric Cancer. BioMed Central, 2006.
MLA način citiranjaYamashita, Hiroharu, et al. Hyperfibrinogenemia Is Associated With Lymphatic As Well As Hematogenous Metastasis and Worse Clinical Outcome in T2 Gastric Cancer. BioMed Central, 2006.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.